Cargando…

Potential Adverse Drug Events with Tetrahydrocannabinol (THC) Due to Drug–Drug Interactions

Tetrahydrocannabinol (THC) is the primary psychoactive ingredient in cannabis. While the safety of THC and cannabis has been extrapolated from millennia of recreational use, medical marijuana programs have increased exposure among medically complex individuals with comorbid conditions and many co-pr...

Descripción completa

Detalles Bibliográficos
Autor principal:	Brown, Joshua D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7231229/ https://www.ncbi.nlm.nih.gov/pubmed/32230864 http://dx.doi.org/10.3390/jcm9040919

Ejemplares similares

Potential Adverse Drug Events and Drug–Drug Interactions with Medical and Consumer Cannabidiol (CBD) Use
por: Brown, Joshua D., et al.
Publicado: (2019)

Self-reported adverse events associated with ∆(8)-Tetrahydrocannabinol (Delta-8-THC) Use
por: Leas, Eric C., et al.
Publicado: (2023)

Are adverse effects of cannabidiol (CBD) products caused by tetrahydrocannabinol (THC) contamination?
por: Lachenmeier, Dirk W., et al.
Publicado: (2023)

Glucocorticoids, Stress and Delta-9 Tetrahydrocannabinol (THC) during Early Embryonic Development
por: Kuzma-Hunt, Alexander G., et al.
Publicado: (2021)

Acute human exposure assessment to tetrahydrocannabinol (Δ(9)‐THC)
por: Arcella, Davide, et al.
Publicado: (2020)

Oral Administration of Cannabis and Δ-9-tetrahydrocannabinol (THC) Preparations: A Systematic Review
por: Poyatos, Lourdes, et al.
Publicado: (2020)

Identification of ∆9-tetrahydrocannabinol (THC) impairment using functional brain imaging
por: Gilman, Jodi M., et al.
Publicado: (2022)

Conversion of Cannabidiol (CBD) into Psychotropic Cannabinoids Including Tetrahydrocannabinol (THC): A Controversy in the Scientific Literature
por: Golombek, Patricia, et al.
Publicado: (2020)

The Diels‐Alder Approach towards Cannabinoid Derivatives and Formal Synthesis of Tetrahydrocannabinol (THC)
por: Hurrle, Thomas, et al.
Publicado: (2021)

Effects of Delta-9 Tetrahydrocannabinol (THC) on Oocyte Competence and Early Embryonic Development
por: Misner, Megan J., et al.
Publicado: (2021)

Indeterminacy of cannabis impairment and ∆(9)-tetrahydrocannabinol (∆(9)-THC) levels in blood and breath
por: Wurz, Gregory T., et al.
Publicado: (2022)

Delta-9 tetrahydrocannabinol (THC) inhibits lytic replication of gamma oncogenic herpesviruses in vitro
por: Medveczky, Maria M, et al.
Publicado: (2004)

Default Mode Network in the Effects of Δ9-Tetrahydrocannabinol (THC) on Human Executive Function
por: Bossong, Matthijs G., et al.
Publicado: (2013)

A protocol for the delivery of cannabidiol (CBD) and combined CBD and ∆(9)-tetrahydrocannabinol (THC) by vaporisation
por: Solowij, Nadia, et al.
Publicado: (2014)

Behavioral effects on the offspring of rodent mothers exposed to Tetrahydrocannabinol (THC): A meta-analysis
por: Ramírez, Simón, et al.
Publicado: (2022)

Causation of potential drug to drug interactions alerts, alert overrides, and adverse drug events in critical cardiac patients
por: Mohamed Ariff, A, et al.
Publicado: (2022)

Drug–drug–gene interactions and adverse drug reactions
por: Malki, Mustafa Adnan, et al.
Publicado: (2019)

Beyond THC: The New Generation of Cannabinoid Designer Drugs
por: Fattore, Liana, et al.
Publicado: (2011)

Epigenetic alterations in cytochrome P450 oxidoreductase (Por) in sperm of rats exposed to tetrahydrocannabinol (THC)
por: Acharya, Kelly S., et al.
Publicado: (2020)

Cannabis containing equivalent concentrations of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) induces less state anxiety than THC-dominant cannabis
por: Hutten, Nadia R. P. W., et al.
Publicado: (2022)

Mining reported adverse events induced by potential opioid-drug interactions
por: Chen, Jinzhao, et al.
Publicado: (2020)

Adverse Event Circumstances and the Case of Drug Interactions
por: Soldatos, Theodoros G., et al.
Publicado: (2019)

Safety aspects of protease inhibitors for chronic hepatitis C: adverse events and drug-to-drug interactions
por: Teixeira, Rosângela, et al.
Publicado: (2013)

Adverse drug reactions and drug–drug interactions with over-the-counter NSAIDs
por: Moore, Nicholas, et al.
Publicado: (2015)

MON-010 Effects of Delta-9-Tetrahydrocannabinol (THC) on Oocyte Competence and Early Embryonic Development
por: Misner, Megan, et al.
Publicado: (2020)

Genetic Modulation of Initial Sensitivity to Δ9-Tetrahydrocannabinol (THC) Among the BXD Family of Mice
por: Parks, Cory, et al.
Publicado: (2021)

Brugada Electrocardiogram Pattern Induced by Recreational Delta-8-Tetrahydrocannabinol (THC): A Case Report
por: Jo, Noah Y, et al.
Publicado: (2021)

The Effect of Orally Administered Δ9-Tetrahydrocannabinol (THC) and Cannabidiol (CBD) on Obesity Parameters in Mice
por: Eitan, Adi, et al.
Publicado: (2023)

Potential Pro-Inflammatory Effect of Vitamin E Analogs through Mitigation of Tetrahydrocannabinol (THC) Binding to the Cannabinoid 2 Receptor
por: Manandhar, Anjela, et al.
Publicado: (2022)

Adverse events caused by potential drug-drug interactions in an intensive care unit of a teaching hospital
por: Alvim, Mariana Macedo, et al.
Publicado: (2015)

Preventable adverse drug events in critically ill HIV patients: Is the detection of potential drug-drug interactions a useful tool?
por: Ramos, Grazielle Viana, et al.
Publicado: (2018)

Δ(9)-Tetrahydrocannabinol (THC) impairs visual working memory performance: a randomized crossover trial
por: Adam, Kirsten C. S., et al.
Publicado: (2020)

Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition
por: Arkell, Thomas R., et al.
Publicado: (2019)

Time Trends of Tetrahydrocannabinol (THC) in a 2008–2021 German National Survey of Hemp Food Products
por: Dräger, Hannah, et al.
Publicado: (2022)

Nonsteroidal Anti-inflammatory Drugs Utilization Patterns and Risk of Adverse Events due to Drug-Drug Interactions among Elderly Patients: A Study from Jordan
por: Al-Azayzih, Ahmad, et al.
Publicado: (2020)

Drug-drug interactions with direct oral anticoagulants associated with adverse events in the real world: A systematic review()
por: Li, Allen, et al.
Publicado: (2020)

Database of adverse events associated with drugs and drug combinations
por: Poleksic, Aleksandar, et al.
Publicado: (2019)

Psychiatric Adverse Drug Reactions and Potential Anti-COVID-19 Drug Interactions with Psychotropic Medications
por: Ghasemiyeh, Parisa, et al.
Publicado: (2021)

A Data-Driven Medical Decision Framework for Associating Adverse Drug Events with Drug-Drug Interaction Mechanisms
por: Noor, Adeeb
Publicado: (2022)

Adverse Reactions and Drug–Drug Interactions in the Management of Women with Postmenopausal Osteoporosis
por: Rizzoli, René, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_o9ptuqr0btac9k98300csi789g